JXHL1800094 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-08-15 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-12 | view |
JXHS1900077 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-06-10 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-06-24 | view |
JYHB1700825 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-11-21 | view |
JXHL1500158 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
JYHB1901166 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-10-16 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-19 | view |
JYHB1701259 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-09-29 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2017-10-03 | view |
JXHS1500113 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-12-16 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-20 | view |
JYHB2001112 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-06-30 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-07-01 | view |
JYHB1801042 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-08-31 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-09-05 | view |
JXHL1700010 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-02-06 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-06-27 | view |
JYHB1800328 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-03-22 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-06-12 | view |
JXHS1900076 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-06-10 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-06-24 | view |
JYHB1700827 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-08 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-10-20 | view |
JYHB1900890 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-07-26 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-26 | view |
JYHB1701015 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-08-08 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-19 | view |
JYHB2001113 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-06-30 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-07-01 | view |
JYHB1801041 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-08-31 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2018-09-05 | view |
JXHL1700009 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-02-06 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-06-27 | view |
JYHB1900717 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-22 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-16 | view |
JYHB1700960 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-07-19 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-09 | view |